title: [Cardiovascular complications in immune mediated diseases].
abstract: Immune mediated diseases carry an increased risk of major cardiovascular events (CV) and an increased risk of CV mortality. The increased CV risk appears to be linked directly to chronic inflammation. Various studies have demonstrated that reducing inflammation reduces the incidence of CV complications. We review the epidemiological evidence linking immune mediated diseases and increased CV risk, discuss the causal role of inflammation in the etiopathogenesis and appraise some potential benefits of specific anti-inflammatory therapies.
authors.affiliation: Service de rhumatologie, Département de méredecine interne, HUG, 1211 Genève 14. axel.finckh@hcuge.ch
authors.forename: A
authors.initials: A
authors.lastname: Finckh
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000209:etiology* / Q000276:immunology; D006801:Humans; D007154:Immune System Diseases / Q000150:complications* / Q000503:physiopathology; D007249:Inflammation / Q000150:complications* / Q000188:drug therapy; D012307:Risk Factors
chemical_list: D000893:Anti-Inflammatory Agents